Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
Currently, 10% of cancer chemotherapy is prescribed to patients by means of an oral formulation, but, by 2013, this percentage is predicted to increase to 25%. Oral chemotherapy offers many advantages, including no need for sometimes painful intravenous access, no intravenous drug administration fees, more time at home for patients, and a greater sense of patient autonomy. However, oral cancer chemotherapy also poses challenges, many of which revolve around adherence and safety. These challenges are discussed here. There are few other circumstances in which patient education and the maintenance of institutional safety infrastructure play such an integral role in sustaining favorable cancer clinical outcomes.
Halfdanarson
Thorvardur R
TR
Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa and Iowa City Veterans' Administration Medical Center, Iowa City, IA, USA.
Jatoi
Aminah
A
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010349:Patient Compliance; D010353:Patient Education as Topic; D012646:Self Administration
D000970:Antineoplastic Agents